asa 100 eg 100 mg gastro-resist. tabl.
eg sa-nv - acetylsalicylic acid 100 mg - gastro-resistant tablet - 100 mg - acetylsalicylic acid 100 mg - acetylsalicylic acid
asa sandoz 100 mg tabl.
sandoz sa-nv - acetylsalicylic acid 100 mg - tablet - 100 mg - acetylsalicylic acid 100 mg - acetylsalicylic acid
aspirine 100 100 mg tabl.
bayer sa-nv - acetylsalicylic acid 100 mg - tablet - 100 mg - acetylsalicylic acid 100 mg - acetylsalicylic acid
aspirine fasttabs 500 mg coat. tabl.
bayer sa-nv - acetylsalicylic acid 500 mg - coated tablet - 500 mg - acetylsalicylic acid 500 mg - acetylsalicylic acid
cardioaspirine 100 mg gastro-resist. tabl.
bayer sa-nv - acetylsalicylic acid 100 mg - gastro-resistant tablet - 100 mg - acetylsalicylic acid 100 mg - acetylsalicylic acid
sedergine 500 mg efferv. tabl.
upsa s.a.s. - acetylsalicylic acid 0,5 g - effervescent tablet - 500 mg - acetylsalicylic acid 500 mg - acetylsalicylic acid
nuprin 75mg gastro-resistant tablets
accord healthcare ireland ltd. - acetylsalicylic acid - gastro-resistant tablet - 75 milligram(s) - platelet aggregation inhibitors excl. heparin; acetylsalicylic acid
excedrin
gsk consumer healthcare, israel ltd - acetylsalicylic acid; caffeine; paracetamol - caplets - paracetamol 250 mg; acetylsalicylic acid 250 mg; caffeine 65 mg - paracetamol, combinations excl. psycholeptics - paracetamol, combinations excl. psycholeptics - for temporary relief of the pain of headache, mild to moderate pain associated with migraine headache, pain of menstrual descomfort and pain accompanied by fever.
ibandronic acid sandoz
sandoz gmbh - ibandronic acid - breast neoplasms; neoplasm metastasis; fractures, bone - drugs for treatment of bone diseases, bisphosphonates - ibandronic acid sandoz is indicated for the prevention of skeletal events (pathological fractures, bone complications requiring radiotherapy or surgery) in patients with breast cancer and bone metastases.,
ibandronic acid teva
teva pharma b.v. - ibandronic acid - breast neoplasms; neoplasm metastasis; fractures, bone; osteoporosis, postmenopausal - drugs for treatment of bone diseases - ibandronic acid 50mgibandronic acid teva is indicated for the prevention of skeletal events (pathological fractures, bone complications requiring radiotherapy or surgery) in patients with breast cancer and bone metastases.ibandronic acid 150mgtreatment of osteoporosis in postmenopausal women at increased risk of fracture. a reduction in the risk of vertebral fractures has been demonstrated, efficacy on femoral neck fractures has not been established.